Lewy pathology of the esophagus correlates with the progression of Lewy body disease: a Japanese cohort study of autopsy cases.
Lewy pathology of the esophagus correlates with the progression of Lewy body disease: a Japanese cohort study of autopsy cases.
复制标题
DOI:
10.1007/s00401-020-02233-8
复制
发表时间:
2021-01
影响因子:
12.7
通讯作者:
Murayama S
中科院分区:
文献类型:
--
作者:
Tanei ZI;Saito Y;Ito S;Matsubara T;Motoda A;Yamazaki M;Sakashita Y;Kawakami I;Ikemura M;Tanaka S;Sengoku R;Arai T;Murayama S
Lewy body disease (LBD) is a spectrum of progressive neurodegenerative disorders characterized by the wide distribution of Lewy bodies and neurites in the central and peripheral nervous system (CNS, PNS). Clinical diagnoses include Parkinson’s disease (PD), dementia with Lewy bodies, or pure autonomic failure. All types of LBD are accompanied by non-motor symptoms (NMSs) including gastrointestinal dysfunctions such as constipation. Its relationship to Lewy body-related α-synucleinopathy (Lewy pathology) of the enteric nervous system (ENS) is attracting attention because it can precede the motor symptoms. To clarify the role of ENS Lewy pathology in disease progression, we performed a clinicopathological study using the Brain Bank for Aging Research in Japan. Five-hundred and eighteen cases were enrolled in the study. Lewy pathology of the CNS and PNS, including the lower esophagus as a representative of the ENS, was examined via autopsy findings. Results showed that one-third of older people (178 cases, 34%) exhibited Lewy pathology, of which 78 cases (43.8%) exhibited the pathology in the esophagus. In the esophageal wall, Auerbach’s plexus (41.6%) was most susceptible to the pathology, followed by the adventitia (33.1%) and Meissner’s plexus (14.6%). Lewy pathology of the esophagus was significantly associated with autonomic failures such as constipation (p < 0.0001) and among PNS regions, correlated the most with LBD progression (r = 0.95, p < 0.05). These findings suggest that the propagation of esophageal Lewy pathology is a predictive factor of LBD. The online version of this article (10.1007/s00401-020-02233-8) contains supplementary material, which is available to authorized users.
登录
查看更多内容
影响因子:
12.7
作者:
Doppler K;Ebert S;Uçeyler N;Trenkwalder C;Ebentheuer J;Volkmann J;Sommer C
通讯作者:
Sommer C
影响因子:
4.4
作者:
Del Tredici, Kelly;Duda, John E.
通讯作者:
Duda, John E.
DOI:
10.1093/jnen/61.5.413
发表时间:
2002-05-01
影响因子:
3.2
作者:
Del Tredici, K;Rüb, U;Braak, H
通讯作者:
Braak, H
影响因子:
9.9
作者:
Chahine LM;Beach TG;Brumm MC;Adler CH;Coffey CS;Mosovsky S;Caspell-Garcia C;Serrano GE;Munoz DG;White CL 3rd;Crary JF;Jennings D;Taylor P;Foroud T;Arnedo V;Kopil CM;Riley L;Dave KD;Mollenhauer B;Systemic Synuclein Sampling Study
通讯作者:
Systemic Synuclein Sampling Study
影响因子:
21.3
作者:
Fujiwara, H;Hasegawa, M;Iwatsubo, T
通讯作者:
Iwatsubo, T